You are here: Industry Insights > SEC

News List

MiNK Therapeutics Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering firstwordpharma
July 29, 2021
MiNK Therapeutics today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") relating to the proposed initial public offering of its common stock.
AzurRx BioPharma Announces Closing of $5.75 Million Bought Deal Offering and Exercise in Full of Underwriter’s Option to Purchase Additional Shares firstwordpharma
July 28, 2021
AzurRx BioPharma, Inc. announced today the closing of its previously announced underwritten public offering of 10,454,546 shares of common stock of the Company.
Caribou Biosciences Announces Closing of Upsized Initial Public Offering firstwordpharma
July 28, 2021
Caribou Biosciences, Inc., (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today the closing of its previously announced initial public offering of 19,000,000 shares of common stock, at a price to the pu
AzurRx BioPharma Announces $3.0 Million Bought Deal Offering of Common Stock firstwordpharma
July 23, 2021
AzurRx BioPharma, Inc. announced today that it has entered into an underwriting agreement with H.C. Wainwright & Co., LLC under which the underwriter has agreed to purchase on a firm commitment basis 5,454,546 shares of common stock of the Company.
TRACON Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock firstwordpharma
July 22, 2021
TRACON today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co. under which the underwriter has agreed to purchase on a firm commitment basis 2,617,802 shares of the Company's common stock
Erasca Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares firstwordpharma
July 21, 2021
Erasca, Inc. (Nasdaq: ERAS) today announced the closing of its initial public offering of 21,562,500 shares of common stock, which includes the exercise in full by the underwriters of their option to purchase 2,812,500 additional shares.
Cytokinetics Announces Proposed Public Offering of Common firstwordpharma
July 20, 2021
Cytokinetics, Incorporated (Nasdaq:CYTK) today announced plans to offer, subject to market and other conditions, $200,000,000 of shares of its common stock in an underwritten public offering.
Immunic, Inc. Announces Closing of $45.0 Million Public Offering firstwordpharma
July 20, 2021
Immunic, Inc. (Nasdaq: IMUX) announced the closing of an underwritten public offering of 4,500,000 shares of its common stock at a public offering price of $10.00 per share.
TransCode Therapeutics, Inc. Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters' Over-allotment Option firstwordpharma
July 14, 2021
TransCode Therapeutics, Inc. (Nasdaq: RNAZ) ("TransCode" or the "Company") today announced the closing of its initial public offering of 7,187,500 shares of its common stock at a public offering price of $4.00 per share.
Imara Announces Launch of Proposed Public Offering firstwordpharma
July 14, 2021
Imara Inc. (the "Company") (Nasdaq: IMRA) today announced that it has commenced a proposed underwritten public offering of $50 million of shares of its common stock. All of the shares are being offered by the Company.

Previous page 1 2 3 4 5 Next page